35186-98-2 Usage
Uses
Used in Pharmaceutical Development:
7-HYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID is used as a potential drug candidate for its pharmacological activities, which may contribute to the treatment of various diseases and disorders. Its potential therapeutic applications are currently under investigation, with the aim of fully understanding its medicinal potential.
Used in Antioxidant Applications:
In the field of health and wellness, 7-HYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID is used as an antioxidant, potentially protecting cells from damage caused by reactive oxygen species and contributing to overall health maintenance.
Used in Anti-inflammatory Applications:
7-HYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID is utilized as an anti-inflammatory agent, potentially reducing inflammation and associated symptoms in various conditions, thereby improving patient outcomes.
Used in Neuroprotective Applications:
In the context of neurological health, 7-HYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID is used as a neuroprotective agent, potentially safeguarding neurons from damage and degeneration, which could be beneficial in the treatment of neurodegenerative diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 35186-98-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,1,8 and 6 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 35186-98:
(7*3)+(6*5)+(5*1)+(4*8)+(3*6)+(2*9)+(1*8)=132
132 % 10 = 2
So 35186-98-2 is a valid CAS Registry Number.
35186-98-2Relevant academic research and scientific papers
ISOQUINOLINE DERIVATIVES
-
Page/Page column 114-115, (2010/02/13)
The present invention relates to isoquinoline derivatives of formula (I), the use of the compounds of formula (I), as inhibitors of one or more kinases, the use of the compounds of formula (I), for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.
Synthesis of 7-phenylethoxy-1,2,3,4-tetrahydroiso- quinoline derivatives
Caubert, Virginie,Viaud-Massuard, Marie-Claude
, p. 175 - 180 (2007/10/03)
Synthesis of 7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives is described, from diiodotyrosine, using a Pictet-Spengler reaction and further O-alkylation of the aromatic ring providing compounds (1) and (2).
